| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |